MarketInOut Stock Screener Log In | Sign Up
 

Moderna Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/10/2026 15:25
Moderna Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization57,987 mln
Float327 mln
Earnings Date10/29/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-3.83
Highly reliable

1-Year Forecast

116
Limited downside

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

0.19
Very low leverage

Pre-Tax Margin

-140%
Severely loss-making

Business Description

Moderna is a biotechnology company founded in 2010 and based in Cambridge, Massachusetts, that develops medicines using messenger RNA technology. Its work spans a broad range of health challenges, including vaccines for respiratory illnesses, viral infections, and bacterial diseases, as well as treatments for certain cancers and rare genetic conditions. The company works alongside notable partners such as Merck, Vertex Pharmaceuticals, the Bill & Melinda Gates Foundation, and OpenAI to advance its research and bring new treatments to patients across the United States and around the world.

Key Fundamentals

EPS-7.98
ROE-37.92
RPS5.66
ROIC-49.53
ROA-26.73
EBITDA, mln-2,804
EV / EBITDA-18.27
EV / EBIT-16.83
Revenue, mln2,210
EV / Revenue23.19

Financial Strength

Altman Z-Score8.17
Piotroski F-Score 1 / 9
Beneish M-Score-3.83
Price to Intrinsic Value2.92
1-Year Target Price116
Shiller PE Ratio110
Short Ratio9.92
Short % of Float16.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.4% 8 / 100   
1 Month 123% 100 / 100   
2 Months 175% 100 / 100   
6 Months 141% 98 / 100   
1 Year 452% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us